-
Your Cheat Sheet For Q1 Biotech Earnings
Thursday, April 6, 2017 - 12:47pm | 699Read More...Previewing first-quarter results of biotech companies, Jefferies said it sees some modest misses across the board, going by its deduction that the first quarter tends to be soft and its Rx analysis. However, the firm said this perspective would not dampen its enthusiasm, given a recent string of...
-
Gilead Sciences Falls Ever-So-Slightly After Q4 Earnings Beat
Tuesday, February 4, 2014 - 5:46pm | 213Read More...Gilead Sciences (NASDAQ: GILD) is down less than one percent in after hours trading after the company announced its fourth quarter results. The company reported a Q4 EPS of $0.55 versus the Street estimate of $0.50. Earnings per share were up 10 percent from the year-ago period. Revenue arrived...
